GGiantBullStocks

Head to head

Halozyme Therapeutics, Inc. (HALO)vsResMed Inc. (RMD)

Price & valuation

MetricHALORMD
Price$103.12$211.94
Change+20.24%-5.06%
Market cap
P/E ratio
EPS
52-week high
52-week low
Volume7,529,9723,424,166

Latest annual financials

MetricHALORMD
Revenue$1.4B$5.15B
Net income$316.89M$1.4B
EPS$2.56$9.51